CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at Chardan’s Virtual 4th Annual Genetic Medicines Conference on Monday, October 5, 2020 at 9 a.m. ET.
A live webcast of Intellia’s presentation will be accessible through the Events and Presentations page of the Investors & Media section of the company’s website at www.intelliatx.com. To access the webcast, please log on approximately 15 minutes prior to the start time, to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Intellia’s website for approximately 14 days following the live event.Intellia Contacts:Investors:
Lina Li
Associate Director
Investor Relations
+1 857-706-1612
lina.li@intelliatx.comMedia:
Jennifer Mound Smoter
Senior Vice President
External Affairs & Communications
+1 857-706-1071
jenn.smoter@intelliatx.com
Bay Street News